Stockreport

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF Reported EPS is $-0.61, expectations were $-0.85. MLYS isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here [Read more]